Share
Contemporary Issues in Evaluating Treatment Outcomes in Neurodevelopmental Disorders (Volume 62) (International Review of Research in Developmental Disabilities, Volume 62)
Esbensen, Anna ; Schworer, Emily (Author)
·
Academic Press
· Hardcover
Contemporary Issues in Evaluating Treatment Outcomes in Neurodevelopmental Disorders (Volume 62) (International Review of Research in Developmental Disabilities, Volume 62) - Esbensen, Anna ; Schworer, Emily
£ 130.50
£ 145.00
You save: £ 14.50
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Monday, July 15 and
Thursday, July 18.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Contemporary Issues in Evaluating Treatment Outcomes in Neurodevelopmental Disorders (Volume 62) (International Review of Research in Developmental Disabilities, Volume 62)"
Contemporary Issues in Evaluating Treatment in Neurodevelopmental Disorders, Volume 62 in the International Review of Research in Developmental Disabilities series, highlights new advances in the field, with this new volume presenting interesting chapters on topics such as Considerations for measuring individual outcomes across contexts in Down syndrome: Implications for research and clinical trials, Remotely Monitoring Development and Treatment Outcomes in Families affected by IDD, Psychometric perspectives on developmental outcome and endpoint selection in treatment trials for genetic conditions associated with neurodevelopmental disorder, Evaluating Outcomes within Culturally Diverse Contexts for Children and Youth with Developmental Disabilities, and much more. Other chapters in this release cover Measurement of Social Skills Treatment Outcome in Autism: Moving Beyond Informant Report and Considering Diversity, Cognitive Outcome Measures for tracking Alzheimer's Disease in Down syndrome, A Scoping Review of Psychosocial Interventions for Neurogenetic Conditions across the Lifespan, Clinical Trials and Outcome Measures: Lessons Learned from Chromosome 15 disorders, and more.
